日本語
 
Help Privacy Policy ポリシー/免責事項
  詳細検索ブラウズ

アイテム詳細

登録内容を編集ファイル形式で保存
 
 
ダウンロード電子メール
  Myf5 and Myogenin in the development of thymic myoid cells - Implications for a murine in vivo model of myasthenia gravis

Hu, B., Simon-Keller, K., Kueffer, S., Stroebel, P., Braun, T., Marx, A., & Porubsky, S. (2016). Myf5 and Myogenin in the development of thymic myoid cells - Implications for a murine in vivo model of myasthenia gravis. EXPERIMENTAL NEUROLOGY, 277, 76-85. doi:10.1016/j.expneurol.2015.12.010.

Item is

基本情報

表示: 非表示:
アイテムのパーマリンク: https://hdl.handle.net/21.11116/0000-0001-BFF6-3 版のパーマリンク: https://hdl.handle.net/21.11116/0000-0001-DA45-C
資料種別: 学術論文

ファイル

表示: ファイル

関連URL

表示:

作成者

表示:
非表示:
 作成者:
Hu, Bo, 著者
Simon-Keller, Katja, 著者
Kueffer, Stefan, 著者
Stroebel, Philipp, 著者
Braun, Thomas1, 著者           
Marx, Alexander, 著者
Porubsky, Stefan, 著者
所属:
1Cardiac Development and Remodeling, Max Planck Institute for Heart and Lung Research, Max Planck Society, ou_2591698              

内容説明

表示:
非表示:
キーワード: ACETYLCHOLINE-RECEPTOR; T-CELLS; SKELETAL-MUSCLE; TARGETED INACTIVATION; THYMOMA; TITIN; AUTOANTIBODIES; ANTIBODIES; MICE; GENENeurosciences & Neurology; Mouse model; Myasthenia gravis; Myf5; Myogenin; Thymic myoid cell; Thymus; AIRE;
 要旨: Myasthenia gravis (MG) is caused by autoantibodies against the neuromuscular junction of striated muscle. Most MG patients have autoreactive T- and B-cells directed to the acetylcholine receptor (AChR). To achieve immunologic tolerance, developing thymocytes are normally eliminated after recognition of self-antigen-derived peptides. Presentation of muscle-specific antigens is likely achieved through two pathways: on medullary thymic epithelial cells and on medullary dendritic cells cross-presenting peptides derived from a unique population of thymic myoid cells (TMC). Decades ago, it has been hypothesized that TMC play a key role in the induction of immunological tolerance towards skeletal muscle antigens. However, an experimental model to address this postulate has not been available. To generate such a model, we tested the hypothesis that the development of TMC depends on myogenic regulatory factors. To this end, we utilized Myf5-deficient mice, which lack the first wave of muscle cells but form normal skeletal muscles later during development, and Myogenin-deficient mice, which fail to form differentiated myofibers. We demonstrate for the first time that Myf5- and Myogenin-deficient mice showed a partial or complete, respectively, loss of TMC in an otherwise regularly structured thymus. To overcome early postnatal lethality of muscle-deficient, Myogenin-knockout mice we transplanted Myogenin-deficient fetal thymuses into Fox(nu/nu) mice that lack their own thymus anlage. We found that the transplants are functional but lack TMC. In combination with established immunization strategies (utilizing AChR or Titin), this model should enable us in the future testing the hypothesis that TMC play an indispensable role in the development of central tolerance towards striated muscle antigens. (C) 2015 Elsevier Inc. All rights reserved.

資料詳細

表示:
非表示:
言語: eng - English
 日付: 2016
 出版の状態: 出版
 ページ: 10
 出版情報: -
 目次: -
 査読: -
 識別子(DOI, ISBNなど): ISI: 000371194800009
DOI: 10.1016/j.expneurol.2015.12.010
 学位: -

関連イベント

表示:

訴訟

表示:

Project information

表示:

出版物 1

表示:
非表示:
出版物名: EXPERIMENTAL NEUROLOGY
種別: 学術雑誌
 著者・編者:
所属:
出版社, 出版地: 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA : ACADEMIC PRESS INC ELSEVIER SCIENCE
ページ: - 巻号: 277 通巻号: - 開始・終了ページ: 76 - 85 識別子(ISBN, ISSN, DOIなど): ISSN: 0014-4886